Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

31
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K
Dementia01:30

Dementia

685
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
685
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial Tissue Gene Expression Associated With Telomere Length Attrition in Coronary Artery Disease.

Journal of lipid and atherosclerosis·2026
Same author

Comparative analysis of pathways induced by TMAO and TNF-α in human microvascular endothelial cells.

Scientific reports·2026
Same author

Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases.

Journal of neurology·2026
Same author

Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.

NeuroImage. Clinical·2026
Same author

Proceedings of the 12<sup>th</sup> International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026
Same author

Intrinsic changes in cell differentiation and identity drive impaired wound healing in aged female murine skin.

Biogerontology·2025

Related Experiment Video

Updated: Apr 28, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K

Frontotemporal dementia and its subtypes: a genome-wide association study.

Raffaele Ferrari1, Dena G Hernandez2, Michael A Nalls3

  • 1Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas, USA; Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

The Lancet. Neurology
|June 20, 2014
PubMed
Summary
This summary is machine-generated.

This study identified new genetic risk loci for frontotemporal dementia (FTD). Findings suggest immune system and lysosomal pathways may play a role in FTD development.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

20.2K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Related Experiment Videos

Last Updated: Apr 28, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

20.2K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Area of Science:

  • Genetics
  • Neuroscience
  • Immunology

Background:

  • Frontotemporal dementia (FTD) is a complex neurodegenerative disorder with diverse clinical, pathological, and genetic features.
  • Known genetic causes of FTD include mutations in MAPT, GRN, and C9orf72 genes.
  • Identifying novel genetic risk factors is crucial for understanding FTD pathogenesis.

Purpose of the Study:

  • To identify novel genetic risk loci associated with frontotemporal dementia (FTD).
  • To investigate the genetic underpinnings of FTD subtypes.
  • To explore the potential biological pathways implicated in FTD through genetic associations.

Main Methods:

  • A two-stage genome-wide association study (GWAS) was conducted involving 3526 FTD patients and 9402 healthy controls of European ancestry.
  • Association analyses were performed for FTD subtypes, followed by meta-analysis and replication in independent cohorts.
  • Expression and methylation quantitative trait loci (eQTL/mQTL) analyses were performed for significant single-nucleotide polymorphisms (SNPs).

Main Results:

  • Genome-wide significant associations were found at the 6p21.3 HLA locus (immune system) for SNPs rs9268877, rs9268856, and rs1980493.
  • A suggestive novel locus at 11q14, near RAB38/CTSC (lysosomal biology), was identified for the behavioral variant FTD subtype (rs302668).
  • eQTL and mQTL analyses indicated that these loci may influence gene expression and methylation in cis.

Conclusions:

  • The study implicates immune system processes (6p21.3) and potentially lysosomal and autophagy pathways (11q14) in FTD.
  • These findings highlight potential novel biological mechanisms contributing to FTD.
  • Further replication studies are needed to confirm these associations and elucidate the pathomechanisms involved in FTD.